Cozad Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.5M | Buy |
34,791
+25,451
| +272% | +$1.96M | 0.2% | 117 |
|
|
2025
Q4 | $741K | Buy |
9,340
+1,905
| +26% | +$150K | 0.06% | 252 |
|
|
2025
Q3 | $561K | Sell |
7,435
-395
| -5% | -$27.1K | 0.04% | 283 |
|
|
2025
Q2 | $539K | Buy |
7,830
+1,500
| +24% | +$98.4K | 0.05% | 277 |
|
|
2025
Q1 | $429K | Sell |
6,330
-202
| -3% | -$12.1K | 0.04% | 287 |
|
|
2024
Q4 | $293K | Buy |
6,532
+233
| +4% | +$13.1K | 0.03% | 334 |
|
|
2024
Q3 | $396K | Sell |
6,299
-3,750
| -37% | -$219K | 0.04% | 290 |
|
|
2024
Q2 | $593K | Sell |
10,049
-2,740
| -21% | -$171K | 0.06% | 238 |
|
|
2024
Q1 | $1.02M | Sell |
12,789
-21,437
| -63% | -$1.64M | 0.11% | 187 |
|
|
2023
Q4 | $2.7M | Sell |
34,226
-2,159
| -6% | -$154K | 0.31% | 91 |
|
|
2023
Q3 | $2.54M | Sell |
36,385
-16,471
| -31% | -$1.17M | 0.33% | 84 |
|
|
2023
Q2 | $3.65M | Sell |
52,856
-61,655
| -54% | -$4.39M | 0.46% | 60 |
|
|
2023
Q1 | $8.51M | Buy |
114,511
+3,997
| +4% | +$335K | 1.13% | 21 |
|
|
2022
Q4 | $10.3M | Sell |
110,514
-1,538
| -1% | -$148K | 1.45% | 8 |
|
|
2022
Q3 | $10.7M | Sell |
112,052
-2,278
| -2% | -$225K | 1.73% | 6 |
|
|
2022
Q2 | $10.6M | Buy |
114,330
+2,418
| +2% | +$236K | 1.65% | 8 |
|
|
2022
Q1 | $11.3M | Buy |
111,912
+6,707
| +6% | +$705K | 1.59% | 10 |
|
|
2021
Q4 | $10.9M | Buy |
105,205
+7,358
| +8% | +$680K | 1.54% | 12 |
|
|
2021
Q3 | $8.3M | Buy |
97,847
+9,358
| +11% | +$784K | 1.29% | 18 |
|
|
2021
Q2 | $7.38M | Sell |
88,489
-3,712
| -4% | -$304K | 1.16% | 22 |
|
|
2021
Q1 | $6.94M | Buy |
92,201
+9,724
| +12% | +$708K | 1.13% | 24 |
|
|
2020
Q4 | $5.63M | Sell |
82,477
-6,094
| -7% | -$396K | 1.01% | 28 |
|
|
2020
Q3 | $5.17M | Buy |
88,571
+22,770
| +35% | +$1.42M | 0.98% | 30 |
|
|
2020
Q2 | $4.28M | Buy |
65,801
+6,433
| +11% | +$405K | 0.87% | 31 |
|
|
2020
Q1 | $3.52M | Buy |
59,368
+20,498
| +53% | +$1.37M | 1.22% | 20 |
|
|
2019
Q4 | $2.89M | Buy |
38,870
+100
| +0.3% | +$7.02K | 0.77% | 36 |
|
|
2019
Q3 | $2.44M | Buy |
38,770
+142
| +0.4% | +$8.41K | 0.71% | 42 |
|
|
2019
Q2 | $2.1M | Sell |
38,628
-39,016
| -50% | -$2.1M | 0.61% | 50 |
|
|
2019
Q1 | $4.19M | Buy |
77,644
+7,341
| +10% | +$453K | 1.26% | 18 |
|
|
2018
Q4 | $4.61M | Buy |
70,303
+25,052
| +55% | +$1.87M | 1.59% | 14 |
|
|
2018
Q3 | $3.56M | Buy |
45,251
+1,881
| +4% | +$134K | 1.04% | 24 |
|
|
2018
Q2 | $2.79M | Buy |
+43,370
| New | +$2.86M | 0.87% | 30 |
|
Other funds holding CVS
VCM
VPM
Cozad Asset Management's CVS Position: Q1 2026 in Review
Cozad Asset Management increased its CVS Health (CVS) stake by 272% in Q1 2026, buying an estimated $1.96M and bringing the position to 34,791 shares worth $2.5M. The position accounts for 0.2% of the portfolio, ranked #117.
Cozad Asset Management first reported a position in CVS in Q2 2018 and has held it in 32 quarters since. The position peaked at $11.3M in Q1 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Cozad Asset Management held 34,791 shares of CVS Health worth $2.5M as of Q1 2026.
- Cozad Asset Management bought 25,451 CVS Health shares in Q1 2026, an estimated $1.96M.
- CVS Health made up 0.2% of Cozad Asset Management's portfolio in Q1 2026, its #117 holding.
- Cozad Asset Management first reported a position in CVS Health in Q2 2018 and has held it in 32 quarters since.
- Cozad Asset Management's CVS Health position peaked at $11.3M in Q1 2022.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Cozad Asset Management's 13F filing for Q1 2026, filed 28 May 2026.